CLINICAL_TRIALS
trial_result
· 2024-10-02
Clinical Trial Update: A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants [Phase 1]
Summary
Phase 1 multiple-dose study of LY3502970 in healthy overweight and obese participants has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Healthy, Obese | Phase 1 | Status: COMPLETED